Cyclin-dependent kinases (CDKs) drive and coordinate multiple cell-cycle events, including construction and contraction of the actomyosin ring during cytokinesis. However, it remains unclear whether CDKs regulate cytokinesis by directly targeting components of the ring. In a search for proteins containing consensus CDK phosphorylation sites in Candida albicans, we found that the IQGAP Iqg1 contains two dense clusters of 19 such sites flanking the actin-interacting CH domain. Here, we show that Iqg1 is indeed a phosphoprotein that undergoes cell-cycle-dependent phosphorylation and can be phosphorylated by purified Clb-Cdc28 kinases in vitro. Mass spectrometry identified several phosphoserine and phosphothreonine residues among these CDK sites. Mutating 15 of the CDK phosphorylation sites with alanine markedly reduced Iqg1 phosphorylation in vivo. The 15A mutation greatly stabilized Iqg1, caused both premature assembly and delayed disassembly of the actomyosin ring, blocked Iqg1 interaction with the actin-nucleating proteins Bni1 and Bnr1, and resulted in defects in cytokinesis. Our data therefore strongly support the idea that the Cdc28 CDK regulates cytokinesis partly by directly phosphorylating the actomyosin ring component Iqg1.
Introduction
The actin cytoskeleton has an important function in many cellular processes such as morphogenesis, motility, trafficking, and cytokinesis (Pruyne and Bretscher, 2000) . There are two conserved actin-assembly machineries: formins and the actin-related protein 2/3 complex. The former assembles linear actin filaments (Evangelista et al, 1997; Pruyne et al, 2002) , whereas the latter generates actin meshworks (Goley and Welch, 2006) . Actin assembly and dynamics are under rigorous spatiotemporal controls. Among many actin regulators, the Rho GTPases Cdc42 and Rac often have an important function (Tapon and Hall, 1997; Bishop and Hall, 2000; Ridley, 2006) . IQGAPs have recently emerged as important regulators of actin (Noritake et al, 2005; Brown and Sacks, 2006; . These conserved proteins contain multiple domains including an N-terminal calponin homology domain (CHD), IQ motifs, and a C-terminal GTPase-activating-protein (GAP)-related domain (GRD). CHD can bind and bundle actin filaments (Fukata et al, 1997; Mateer et al, 2004) , GRD interacts with Cdc42 and Rac (Bashour et al, 1997; Swart-Mataraza et al, 2002; Noritake et al, 2004) , and the IQ motifs interact with calmodulin and myosin light chains (Shannon and Li, 1999; Boyne et al, 2000) . Human IQGAP1 also contains a C-terminal region that mediates interactions with the formin Dia1. IQGAPs form scaffolds that recruit key components of the actin assembly machinery and can promote actin polymerization (Hart et al, 1996; Le Clainche et al, 2007) . recently reported that IQGAP1 is necessary for Dia1 to localize to the leading edge of migrating cells and to the phygocytic cups. IQGAP functions are regulated at multiple levels. Rho GTPases control cellular localizations and functions of mammalian IQGAPs (Briggs and Sacks, 2003; Izumi et al, 2004) . IQGAP1 is regulated by autoinhibition through intramolecular interactions, which is relieved by protein kinase Ce phosphorylation of Ser1443 (Grohmanova et al, 2004; Li et al, 2005b) .
Studies in Saccharomyces cerevisiae have provided many key insights into the regulation and function of IQGAPs (Epp and Chant, 1997; Lippincott and Li, 1998; Shannon and Li, 1999; Lippincott et al, 2001; Tolliday et al, 2002; Ko et al, 2007) . Iqg1 is the only IQGAP homologue in this yeast and has an important function in cytokinesis. It localizes to the bud neck in anaphase and controls assembly and contraction of the actomyosin ring. After cytokinesis, Iqg1 undergoes ubiquitin-mediated proteolysis (Ko et al, 2007) . Two formins Bni1 and Bnr1 also localize to the neck and are required for assembling the actomyosin ring (Tolliday et al, 2002) . In spite of their colocalization and shared cellular functions, it is not clear how Iqg1 and formin cooperate in the dynamics and functions of the ring in a cell-cycle-dependent manner.
The cyclin-dependent kinase (CDK) Cdc28 controls initiation and termination of key cell-cycle events including cytokinesis (Murray, 2004) . Satterwhite et al (1992) reported that in Xenopus the Cdc2 kinase regulates the timing of cytokinesis by phosphorylating the regulatory light chain of myosin-II. Thus, it is an attractive idea that regulation of cytokinesis in yeast might involve Iqg1 phosphorylation by Cdc28. Incidentally, Li and his colleague first noticed the presence of four perfect consensus CDK phosphorylation sites in the N-terminal part of Iqg1 (Lippincott and Li, 1998) . However, it remains unknown whether Iqg1 is a direct regulatory target of Cdc28.
In recent years, the polymorphic fungus Candida albicans has become a useful model for elucidating mechanisms that control polarized growth (Zheng et al, 2004 (Zheng et al, , 2007 Court and Sudbery, 2007; Sinha et al, 2007) . This organism can switch between yeast and hyphal growth. Although core components of the polarity machinery are highly conserved in eukaryotic cells, unique elements have evolved in C. albicans specifically for the control of hyphal development. For example, C. albicans uses a hypha-specific cyclin-CDK complex, Hgc1-Cdc28, to regulate phosphorylation of two septins Cdc11 (Sinha et al, 2007) and Sep7 (González-Novo et al, 2008) and the Cdc42 GAP Rga2 to maintain hyphal growth (Zheng et al, 2007) .
To identify Hgc1-Cdc28 substrates, we have systematically scanned for consensus CDK sites in C. albicans proteins that had been implicated in regulating the actin cytoskeleton. One protein we found is Iqg1 whose N-terminal end contains 8 perfect (S/TPxR/K, x is any amino acid (aa)) and 10 minimal (S/TP) consensus sites for CDK phosphorylation. In this study, we took advantage of this property to study whether Cdc28 directly phosphorylates and regulates Iqg1 in C. albicans.
Results

Domain organization of C. albicans Iqg1
The C. albicans genome (Arnaud et al, 2007) contains one open-reading frame (orf19.6536) annotated as the orthologue of S. cerevisiae (Sc) IQG1. This CaIqg1 contains 1647 aa and is B20% identical to ScIqg1. Sequence analysis using the SMART program (Letunic et al, 2006) identified a CHD and a GRD (Figure 1 ) at positions similar to the same domains in human IQGAP1 and ScIqg1. This program did not find any IQ motifs. However, visual scanning of the sequence revealed several motifs resembling the consensus IQ sequence IQxxxRGxxxRS (Epp and Chant, 1997) in similar regions of ScIqg1 and CaIqg1 ( Figure 1A and B) . Interestingly, the residue in front of the conserved glutamine (Q) is more often to be leucine than isoleucine in the fungal proteins, which may be one reason why the SMART program failed to identify these motifs. Strikingly, we also found 21 consensus CDK phosphorylation sites, including 8 perfect and 13 minimal ones (Supplementary Table S1 ). And 11 sites are clustered between aa 39 and 180, and 7 sites between aa 324 and 455, closely flanking CHD. In comparison, ScIqg1 contains 4 perfect and 16 minimal sites, among which all the perfect and 10 minimal sites are also organized in two clusters flanking CHD. In contrast, IQGAP1 contains only four widely scattered minimal sites. The clustering of CDK sites in both ScIqg1 and CaIqg1 implies critical functionality in fungi, which might be under the control of CDKs.
CaIqg1 cellular localizations
To confirm that CaIqg1 is the counterpart of ScIqg1, we first examined its cellular localization. The protein was N-terminal tagged with the green fluorescent protein (GFP) and expressed from its native promoter. GFP-Iqg1 is functional as judged by the lack of any discernible defects when expressed as the sole source of this protein; functionality of all proteins tagged in this study were verified by the same criterion (data not shown). Microscopic examination of yeast cells revealed that Iqg1 localized to the bud neck immediately after bud emergence. The neck localization was observed in all small-to medium-budded and most large-budded cells ( Figure 2A ; Table I ). Although the GFP signal was often seen as a bar across the bud neck, when properly angled, it appeared as a ring. In some large-budded cells, GFP-Iqg1 appeared as a dot in the centre of the neck, presumably the result of contraction of the actomyosin ring, of which Iqg1 is a component (Lippincott and Li, 1998; Shannon and Li, 1999) . The Iqg1 ring contraction was confirmed by timelapse microscopy ( Figure 2B ). We noticed that the ring fluorescence was weak in cells with small-to medium-sized buds and became markedly stronger in large-budded cells. As a result, time-lapse microscopy often failed to capture the ring in the early stages of cell cycle, giving an impression of sudden appearance of the ring in large-budded cells 
This study (Figure 2B) . The data suggest a two-step recruitment of Iqg1 to the neck in C. albicans: at bud emergence and in M phase. This differs apparently from ScIqg1, which localizes to the neck only in anaphase (Epp and Chant, 1997; Lippincott and Li, 1998) .
iqg1D mutants are defective in cytokinesis
To study the functions of CaIqg1, we generated iqg1D/D mutants. Several phenotypes were prominent and consistent with severe cytokinetic defects. First, when grown as yeast, most iqg1D/D cells were elongated and formed chains ( Figure 3A ). However, these cells appeared normal in response to hyphal induction. Second, the chintin dye Calcofluor White failed to stain the septum particularly between cells in a chain ( Figure 3B ). Third, rhodaminephalloidine staining could not detect actin rings at the septum ( Figure 3C ), indicating failure in actomyosin ring assembly. Moreover, the mutant cells are severely swollen with wide necks, suggesting defective bud and neck morphogenesis.
Higher temperatures exacerbated the defects as shown by greater cell elongation and loss of viability at 421C
( Figure 3D ). The data are essentially consistent with the phenotype of Sciqg1D (Epp and Chant, 1997; Lippincott and Li, 1998) . We thus conclude that CaIqg1 is the functional counterpart of ScIqg1. Interestingly, although the majority of iqg1D/D cells failed to separate after cytokinesis, a small number of single cells (o5%) were observed, suggesting the presence of an Iqg1-independent mechanism(s) for cytokinesis.
Iqg1 is a phosphoprotein
The presence of 21 consensus CDK sites in Iqg1 suggested that it might be a Cdc28 substrate. To test this, we tagged Iqg1 with a 6Myc epitope at the N terminus for anti-Myc immunoprecipitation (IP). Phosphorylation was then probed by western blotting using an antibody (aPS) that preferentially recognizes phospho-Ser in consensus CDK sites (Zheng et al, 2007) . We found that aPS strongly reacted with Iqg1 ( Figure 4A ), which was abolished by pretreating the precipitate with l phosphatase (lPPase). As controls, the Myc antibody detected both lPPase-treated and lPPase-untreated Iqg1, and the treated Iqg1 migrated faster as a sharp band in contrast to a diffuse band of the untreated Iqg1. To determine when Iqg1 phosphorylation occurs during the cell cycle, stationary-phase yeast cultures containing 495% G1 cells were used to start synchronous cultures in GMM at 301C. Under this condition, 50% budding occurred at B1.2 h and one cell-cycle time was B100 min. We harvested cells at intervals, immunoprecipitated Myc-Iqg1 using Myc antibody, and then probed the precipitate by western blotting using Myc antibody or aPS ( Figure 4B ). The Myc antibody started to detect Myc-Iqg1 at 1 h, after which the amount of Iqg1 increased gradually and peaked at 2.5 h around the time of cytokinesis. After cytokinesis, the cellular levels of Iqg1 started to decline. Interestingly, aPS could barely detect Myc-Iqg1 at 1 h and started to clearly detect it at 1.5 h, and then the intensity of the signal increased in parallel with the Myc-Iqg1 cellular levels until 3 h when the signal weakened sharply. The results therefore reveal that both the cellular level and phosphorylation status of Iqg1 are regulated in a cell-cycle-dependent manner. To determine whether Cdc28 is involved, we repeated this experiment using a strain coexpressing Myc-Iqg1 and Cdc28as, a mutated Cdc28 sensitive to the ATP analogue 1NM-PP1 . Owing to the high cost of 1NM-PP1, we examined Iqg1 phosphorylation at only two time points. Again, stationary-phase yeast cells were inoculated into two fresh cultures and grown at 301C for 1.5 and 2.5 h, respectively, before further dividing each culture into two; to one culture 1NM-PP1 was added and then both cultures were grown for 30 more minutes before IP and western blotting. Figure 4C shows that 1NM-PP1 abolished Iqg1 phosphorylation, consistent with a function of Cdc28 in regulating Iqg1 phosphorylation. However, the failure in detecting Iqg1 by aPS after 1NM-PP1 treatment also suggests Iqg1 dephosphorylation during the time when
Cdc28as was inhibited. This could be either due to the disturbance of a kinase-phosphatase balance that normally determines levels of protein phosphorylation or due to the activation of a phosphatase during the inhibition of Cdc28as. Although we favour the former explanation, we currently have no evidence to exclude the latter. To map phosphorylation sites, affinity-purified Myc-Iqg1 was analysed by mass spectrometry (MS). The MS data covered B60% of the Iqg1 sequence and detected phosphoSer or phospho-Thr at 21 sites (Supplementary Table S2) including four perfect and five minimal CDK sites ( Figure 4D ). Together, we conclude that Iqg1 is a phosphoprotein and many of the consensus CDK sites are phosphorylated in vivo.
Purified Clb2-Cdc28 complex can phosphorylate Iqg1 in vitro
To determine whether Cdc28 can directly phosphorylate Iqg1, we coexpressed Clb2-HA and Cdc28as, purified the Clb2-HA-Cdc28as complex by anti-HA IP (Supplementary Figure  S1) , and used it to phosphorylate immunopurified Myc-Iqg1 in a kinase assay. Figure 4E shows that the CDK complex could phosphorylate Myc-Iqg1 and the reaction was completely inhibited by 25 mM 1NM-PP1. We had established previously that 1NM-PP1 at concentrations up to 50 mM has no inhibitory effect on WT Cdc28 (Sinha et al, 2007; Zheng et al, 2007) . As negative controls, incubating the purified Myc-Iqg1 alone in the kinase reaction did not cause detectable phosphorylation of Iqg1, nor did the anti-HA precipitate pulled down from cell lysates lacking the HA tag (data not shown). Together, our results strongly support the idea that Iqg1 is a Cdc28 substrate in vivo. Figure 4 Evidence that Iqg1 is a Cdc28 substrate. (A) Lysates were prepared from cells expressing Myc-Iqg1 (LCR26) and immunopurified with Myc antibody (Ab). The precipitate was divided into two parts with one treated with lPPase before western blotting using aPS or Myc Ab. (B) Stationary cells were diluted into fresh YPD for further growth at 301C. Aliquots were harvested at the indicated times for generating the budding index (top) and for IP with Myc Ab, followed by western blotting using aPS or Myc Ab. (C) Stationary cells of LCR11 were first grown in fresh YPD at 301C for 1.5 or 2.5 h and then grown for 30 min in the presence or absence of 25 mM 1NM-PP1. Then, cells were harvested for IP of Myc-Iqg1 with Myc Ab, followed by western blotting using aPS or Myc Ab. (D) List of perfect and minimal consensus CDK phosphorylation sites on Iqg1 identified by MS. (E) Immunopurified Clb2-HA/Cdc28 (JCB64) and Clb2-HA/Cdc28as (LCR10) complexes were used to phosphorylate immunopurified Myc-Iqg1 (LCR26) in a kinase assay containing g-P 32 -ATP in the presence or absence of 25 mM 1NM-PP1. Phosphorylated proteins were visualized by autoradiography after SDS-PAGE. (F) Log-phase cells expressing GFP-Iqg1 together with Cdc28-Myc (LCR7), Clb2-HA (LCR8), or Clb4-HA (LCR9) were lysed for IP with GFP or HA Ab. Cells expressing Cdc28-Myc (LCR6), Clb2-HA (JCB64), or Clb4-HA (JCB77) alone were used as negative controls. For all coIP experiments described in this study, 2-ml lysate was obtained from a 200-ml culture; 30 ml of the lysate was loaded in lanes labelled as L, and all the precipitate from the rest of the lysate was loaded in lanes labelled as IP. The blots were probed with the appropriate Ab. 
Iqg1 physically interacts with Cdc28 and B-type cyclins
To gain further evidence for Iqg1 phosphorylation by Cdc28, we examined whether they associate with each other. A strain was constructed coexpressing GFP-Iqg1 and Cdc28-Myc. We used GFP antibody to pull down GFP-Iqg1 from cell lysates and then used Myc antibody to detect Cdc28-Myc in the precipitate. Figure 4F shows that Cdc28-Myc could indeed coprecipitate with GFP-Iqg1. We also determined whether cyclins are associated with Iqg1. We coexpressed Clb2-HA or Clb4-HA with GFP-Iqg1 and were able to detect coIP of both cyclins with GFP-Iqg1 ( Figure 4F ). However, such interaction was not detected with the G1 cyclin Ccn1 (data not shown), suggesting that Iqg1 may be specifically regulated by ClbCdc28 kinases.
Mutating the CDK sites on Iqg1 causes morphological and cytokinesis defects
To address the biological significance of Iqg1 phosphorylation by CDK, we generated a mutant Iqg1 in which the Ser or Thr residues in all eight perfect CDK sites and the seven minimal sites closest to the N terminus were replaced with Ala (Iqg1-15A). We also constructed a phosphomimetic version replacing the 15 residues with Asp (Iqg1-15E). Each mutant gene was introduced into the IQG1/iqg1D background to replace the WT copy, yielding strains expressing from the native promoter, either Iqg1-15A or Iqg1-15E as the sole source of Iqg1. All versions of Iqg1 were tagged at the N terminus with either GFP or 6Myc. We first assessed phosphorylation levels of Iqg1-15A by western blotting using aPS and found that the intensity of the Iqg1-15A band was drastically reduced compared with the WT Iqg1 band, consistent with Iqg1 phosphorylation at the CDK sites in vivo ( Figure 5A ). Microscopic examinations of iqg1-15A and iqg1-15E cells revealed similar defects in morphology: cell elongation and failure of cytokinesis/separation ( Figure 5B) . However, the defects were more severe in the iqg1-15E mutant. For example, B50% of the iqg1-15E cells had a length-width ratio 42 at 301C compared with B16% of the iqg1-15A cells, and B14% of the latter cells grown at 371C were as long as 30-40 mm, which was seen only in B3% of the former cells. In spite of these defects, these mutants, unlike iqg1D/D, were viable at 421C. Moreover, both mutants were capable of producing separated cells, indicating that many cells could complete cytokinesis. The partial functionality and similar defects of the two Iqg1 mutants suggest that reversible phosphorylation at the CDK sites are important for the functions of Iqg1 in the cell.
Next, we asked whether the CDK-site mutations affect the localization of Iqg1. Examination of asynchronous cultures detected GFP-Iqg1 at the neck of buds of all sizes in both iqg1-15A and iqg1-15E mutants, suggesting that the mutations do not significantly affect the general localization pattern of Iqg1 (data not shown). However, time-lapse microscopy revealed prolonged presence of Iqg1-15A at the bud neck. As the microscope setting for this experiment could clearly capture only the image of GFP-Iqg1 in cells with large buds where the fluorescence was strong, we used the first time point when the fluorescence was unambiguously seen to approximate the start of the neck localization of Iqg1. Figure 5C presents representative series of cell images. WT Iqg1 persisted at the neck for 17.5±2.4 min (n ¼ 20). Strikingly, Iqg1-15A in B30% of the cells persisted for 30-35 min (n ¼ 20), which was rarely seen in WT cells, whereas Iqg1-15E disappeared slightly earlier than WT Iqg1 (16.4±1.9 min, n ¼ 20). The significantly longer persistence of Iqg1-15A suggests that Iqg1 phosphorylation might have an important function in the temporal control of actomyosinring assembly or disassembly or both. To address this issue further, we arrested yeast cells with nocodazole in M phase and then released them into drug-free medium to score the cells with a neck actin ring at intervals ( Figure 6A ). After 2 h of nocodazole treatment, 495% of the cells of all the three strains were large-budded with an undivided nucleus, characteristic of M arrest. Under this condition, rhodaminephalloidine staining detected a neck actin ring in only 4% of WT cells (50 cells per time point). After release, the number of cells with a neck actin ring increased gradually, reached 22% at 30 min and then declined, indicating that actin ring assembly occurs after the mitotic entry, consistent with previous reports for ScIqg1 (Tolliday et al, 2002) . In comparison, although the iqg1-15E cells exhibited a trend similar to WT cells, we clearly detected the actin ring in 22% of the Iqg1-15A cells at the end of the 2-h nocodazole treatment; the percentage of these cells increased gradually after the release and reached 27% at 30 min before declining to 12% at 60 min. The results thus suggest premature assembly of the actomyosin ring in the iqg1-15A mutant. When cells were stained with the DNA dye DAPI to visualize nuclei, the percentage of cells with divided nuclei in all strains were similar at all time points after release from the arrest, indicating that the aberrant actin ring behaviour in iqg1-15A cells is not a result of disturbed nuclear division.
When we assessed cellular levels of Iqg1-15A and Iqg1-15E in asynchronous cells, we consistently found more Iqg1-15A Figure 6 The 15A mutation stabilizes Iqg1 and affects the dynamics of the actomyosin ring. (A) Log-phase cells expressing WT Iqg1 (LCR26), Iqg1-15A (LCR29), or Iqg1-15E (LCR32) as the sole source of Iqg1 were arrested with 30 mM nocodazole for 2 h and then stained with rhodaminephalloidine to reveal the actin ring at the neck and with 4 0 ,6-diamidino-2-phenylindole (DAPI) to visualize nuclei. (B) The nocodazole-arrested cells described in (A) were released into drug-free medium for growth at 301C. Cells were harvested at intervals for actin and nuclear staining. Percentage of cells with a neck actin ring and with divided nuclei was counted. (C) Stationary cells expressing WT Iqg1 (LCR26), Iqg1-15A (LCR29), or Iqg1-15E (LCR32) were released into fresh YPD for growth at 301C. Aliquots were harvested at 0, 1, 2, and 3 h and lysates were prepared for western blotting using Myc Ab (all Iqg1 proteins have a 6Myc tag). Duplicate blots were probed with PSTAIRE Ab to detect Cdc28 as loading controls. (D) Cell lysates prepared as described in (B) and analysed by western blotting using Myc Ab and PSTAIRE Ab. and less Iqg1-15E than WT Iqg1 (data not shown). Prompted by the finding that ScIqg1 undergoes APC-mediated proteolysis at the end of cytokinesis (Ko et al, 2007) , we suspected that the CDK-site mutations might have affected Iqg1 stability. To test this idea, we first determined cellular levels of the Iqg1 mutants during the cell cycle as described in Figure 4B . Stationary-phase cells were released into fresh medium and aliquots were harvested at 1, 2, and 3 h for western blot analysis. We found that whereas both WT Iqg1 and Iqg1-15E were undetectable at 1 h, Iqg-15A was strongly detected, and its level remained virtually constant throughout the cell cycle ( Figure 6C ). Furthermore, Iqg-15E levels were much lower than WT and Iqg1-15A. Next, we repeated the experiment by using cultures released from nocodazole arrest as described in Figure 6B . We found that whereas the levels of all three Iqg1 mutants were similar in the arrested cells, they declined at different rates after release ( Figure 6D ). The level of WT Iqg1 dropped significantly at 30 min and became barely detectable at 45 min. In comparison, degradation of Iqg1-15E occurred earlier, becoming undetectable at 30 min, whereas the level of Iqg1-15A remained unchanged even at 60 min. Thus, the data suggest that Iqg1 phosphorylation at the CDK sites might have a function in determining Iqg1 degradation after cytokinesis.
Mutations of Iqg1 CDK sites influence the disassembly of the actomyosin ring
To understand the physiological significance of Iqg1 phosphorylation by CDK, we next examined the dynamics of GFPMyo1. Similar to Iqg1, GFP-Myo1 was found to localize to the bud neck as a ring when the bud had just emerged (data not shown). Time-lapse microscopy revealed that the neck ring contracted to a dot and then disappeared at the end of cytokinesis (Figure 7) . The time taken from the start of ring contraction to the disappearance of the dot was 6-9 min (n ¼ 12). Interestingly, the GFP-Myo1 ring also exhibited a sudden marked increase in fluorescence intensity during the large-budded stage, reminiscent of the GFP-Iqg1 ring. The neck localization of GFP-Myo1 was largely unaffected in iqg1D/D cells except that the ring did not exhibit the increase in fluorescence intensity and did not contract before disappearance. When we examined GFP-Myo1 in the CDK-site Figure 7 The CDK-site mutations affect the disassembly of the actomyosin ring. GFP-Myo1 in wild-type (LCR35), iqg1D/D (LCR38), iqg1-15A (LCR36), and iqg1-15E (LCR37) mutants was examined by time-lapse microscopy. mutants, we observed the following. First, in iqg1-15E cells, GFP-Myo1 disappeared 2-3 min earlier than in WT cells (n ¼ 10). Second, in all iqg1-15A cells, the GFP-Myo1 dot at the end of the contraction persisted over extended periods of time: the dot did not disappear; instead it was divided into two dots that were inherited one each by the mother and daughter cells. The dots, particularly the ones on the mother side, often persisted into the next cell cycle (n ¼ 7 of 12). We did not detect any significant difference in the rate of ring contraction in the mutants, suggesting that the 15A mutations mainly impair the disassembly of the Myo1 ring after contraction. Taken together, our data suggest that CDK phosphorylation of Iqg1 may have an important function in regulating the dynamics of the actomyosin ring. As GFPIqg1-15A did not exhibit the same behaviour (see Figure 5C ) as GFP-Myo1 in iqg1-15A cells after ring contraction, the two proteins might have disassociated after cytokinesis.
The CDK-site mutations markedly affect the association of Iqg1 with formins
The formins are crucial for actin ring assembly in S. cerevisiae (Tolliday et al, 2002) . Inspired by the recent report of physical and functional interactions between the mammalian IQGAP1 and Dia1, we examined whether Iqg1 interacts with Bni1 and Bnr1 in C. albicans. We coexpressed GFP-Iqg1 with Myc-Bni1 or Myc-Bnr1 and used GFP antibody to pull down GFP-Iqg1 and then Myc antibody to probe Myc-Bni1 or Myc-Bnr1 in the precipitate. This experiment detected Iqg1 coIP with both Bni1 and Bnr1 ( Figure 8A and B). The Iqg1-formin interaction was detected also in reciprocal coIP in which the Myc-tagged formins were pulled down first with Myc antibody and followed by probing GFPIqg1 with GFP antibody (Supplementary Figure S2) . The results thus revealed Iqg1 association with formins. Next, we asked whether this interaction might be regulated by Iqg1 phosphorylation at the CDK sites. To this end, GFP-tagged Iqg1-15A or Iqg1-15E was coexpressed with Myc-Bni1 or Myc-Bnr1. Strikingly, the 15A mutation almost completely abolished the interaction of Iqg1 with both formins ( Figure  8C and D) . Furthermore, although the cellular levels of Iqg1-15E are lower than the WT Iqg1 (see Figure 6C) , the relative amount of formins pulled down with Iqg1-15E was significantly higher than the amount of formins pulled down with the WT Iqg1, suggesting that the 15E mutations enhanced the association of Iqg1 with formin. Thus, the data not only demonstrate the association of Iqg1 with forming, but also suggest that the interaction may be regulated by CDK phosphorylation of Iqg1.
Overexpression of formins partially suppresses the defects of the iqg1-15A and iqg1-15E mutants Next, we explored the possible function of Iqg1 in determining the cellular localizations of formin. In S. cerevisiae, Bni1 and Bnr1 exhibit distinct localization patterns (Pruyne et al, 2004) . We reported that CaBni1, similar to ScBni1, localizes to the presumptive bud site, the tips of small-to mediumsized buds and the neck of large-budded cells (Li et al, 2005a) . However, the localization of CaBnr1 had not been studied in detail. Thus, we first examined GFP-Bnr1 localization in comparison with GFP-Bni1. As the native promoter was too weak for detecting the GFP-tagged formins, we used the stronger MET3 promoter. We observed that Bnr1 formed a ring at the bud neck immediately after the bud became visible, and the neck localization persisted throughout the cell cycle until the end of cytokinesis when the Bnr1 ring split into two rings ( Figure 8E ). In contrast, CaBni1 was seen only at the tips but never at the neck in small-and medium-sized buds; only late in the cell cycle did Bni1 localize to the bud neck. The results show that the C. albicans formins exhibit distinct localization patterns similar to their counterparts in S. cerevisiae.
We next examined GFP-tagged Bni1 and Bnr1 in iqg1D/D, iqg1-15A, and iqg1-15E mutants. To minimize the secondary effects, we focused on the normal-looking yeast cells of the mutants. In iqg1D/D cells, Bnr1 exhibited normal localizations, whereas the signal of Bni1 was hard to detect in small buds and was faint at the neck ( Figure 8F ), suggesting that Iqg1 may influence the localization of Bni1. In the two CDKsite mutants, both formins were found localized normally (data not shown), suggesting that CDK phosphorylation of Iqg1 may not be critical for correct localization of the formins. Unexpectedly, we observed that overexpression of either formin from the MET3 promoter significantly reduced cell elongation in both iqg1-15A and iqg1-15E mutants ( Figure 8G ), indicating a genetic interaction between Iqg1 and formin. We also found that the effect is not due to changes of Iqg1 levels ( Figure 8H ). Similar expression of the formins in iqg1D/D cells had no obvious effect. Thus, the molecular basis of this genetic interaction remains to be further investigated.
Discussion
Iqg1 is a regulatory target of Cdc28
CDKs have an important function in ensuring orderly occurrence of major cell-cycle events, of which cytokinesis is the last critical step. Although actomyosin-based contractile rings are known as a key component of the cytokinesis apparatus, data remain scant on whether CDKs regulate cytokinesis through direct phosphorylation of constituent molecules of the ring. In this study, we have obtained compelling evidence that the CaIqg1 is a likely substrate of Cdc28. First, sequence analysis of Iqg1 revealed dense clusters of consensus CDK sites. Second, we found that Iqg1 is a phosphoprotein in vivo and can be phosphorylated by purified Clb2-Cdc28 kinases in vitro. Third, MS analysis mapped several phospho-Ser and phospho-Thr in consensus CDK sites. Furthermore, we have shown that phosphorylation at these sites is of physiological significance. Mutating 15 CDK sites with Ala caused marked reduction in Iqg1 phosphorylation in vivo, stabilization of Iqg1, premature assembly and delayed disassembly of the actomyosin structure, and abnormal cytokinesis. Hence, our data strongly support the idea that CDKs regulate cytokinesis partly by direct phosphorylation of actomyosin-ring components ( Figure 9) .
We observed opposing effect of Iqg1-15A and Iqg1-15E on certain molecular events such as Iqg1 degradation and its interaction with formin, consistent with the view that the hyper and hypophosphorylated forms of Iqg1 have different functions. However, the two mutants also exhibit similar morphological defects, although of different severity: cell elongation and abnormal cytokinesis. This apparent discrepancy is not totally unexpected for the following reasons. On the basis of the observed temporal control of Iqg1 phospho-rylation ( Figure 4B) , it is reasonable to hypothesize that the phosphorylation status of Iqg1 may define its function at a specific time of the cell cycle. Thus, neither Iqg1-15A nor Iqg1-15E can be expected to be fully functional for all events required of Iqg1 throughout the cell cycle. Moreover, replacing 15 residues with either Ala or Glu is likely to cause The experiment was performed as described in Figure 6C except using LCR27, LCR30, and LCR33. unfavourable structural changes that somewhat compromise the the function of the protein. Consequently, the partially functional versions of Iqg1 may cause defects in some cellular events that need Iqg1, such as actin polarization, bud and neck construction, and cytokinesis. Many mutants, for example, gin4D (Wightman et al, 2004) , cdc10D, or cdc11D (Warenda and Konopka, 2002) , that affect budding or neck formation cause cell elongation. Unlike ScIqg1, CaIqg1 localizes to the bud neck at bud emergence, suggesting that it may contribute to budding and neck formation. Consistently, iqg1D cells are severely swollen with broadened necks ( Figure 3A ). Taken together, the similar morphological defects of iqg1-15A and iqg1-15E mutants may be attributable to abnormalities in budding or neck formation or both, which may have masked the phenotypes specifically associated with each of the CDK-site mutants at morphological levels.
CDK phosphorylation of Iqg1 may have an important function in disassembly of the actomyosin ring
Previous studies in S. cerevisiae and S. pombe as well as this work have established an essential function for IQGAPs in the actomyosin-ring-based mechanism of cytokinesis in fungi (Epp and Chant, 1997; Eng et al, 1998; Lippincott and Li, 1998) . As the central components of the ring are Myo1 and actin, the timing and detailed molecular architecture for assembling the two proteins are predictably important. Myo1 localizes to the bud neck at an early stage of the cell cycle, whereas actin is incorporated into the ring during mitosis (Lippincott and Li, 1998; and this work) . Although Iqg1 is apparently not required for Myo1 localization, it has several important functions in the assembly and contraction of the ring. Shannon and Li (1999) presented evidence that CHD is required for recruiting actin filaments, and GRD is required for ring contraction. Our data largely confirmed the functions of Iqg1 in the assembly and contraction of the actomyosin ring; however, we also discovered that Iqg1 may have a function in determining the timely disassembly of the ring after cytokinesis and that this function is most likely under the control of CDKs. We found that although the WT actomyosin ring, labelled with GFP-Myo1, disappeared within 4 min after contraction to a dot, mutating 15 of the consensus CDK sites to Ala in Iqg1 greatly delayed the disappearance of the dot.
We have found that unlike the cyclic behaviour of the WT Iqg1, the cellular levels of Iqg1-15A remained essentially constant throughout the cell cycle. We suspected that the mutant protein may have become resistant to APC-mediated proteolysis that had been shown to occur to ScIqg1 after cytokinesis (Ko et al, 2007) . Incidentally, the N-terminal region of ScIqg1 appears to have an important function in its ubiquitylation and degradation (Ko et al, 2007) . The results of our nocodazole-arrest-and-release experiments support this view. We found that whereas the cellular level of WT Iqg1 dropped significantly at 30 min and was barely detectable at 45 min after release, the level of Iqg1-15A remained largely unchanged for at least 60 min. Interestingly, the 15E phosphomimetic form of Iqg1 was degraded more rapidly than WT Iqg1. Together, the results suggest that Iqg1 phosphorylation at the CDK sites may have an important function in ensuring a timely degradation of Iqg1, which seems to be important for complete disassembly of the actomyosin complex.
Actomyosin-ring-independent mechanisms for cytokinesis Unlike ScIqg1, CaIqg1 is not essential. Moreover, despite the lack of the actomyosin ring, a small number of Caiqg1D/D cells can complete cytokinesis, suggesting the presence of a cytokinetic mechanism that can function, although much less efficiently, without both Iqg1 and the actomyosin ring. Actomyosin-ring-independent cytokinesis has also been reported in S. cerevisiae. Several studies showed that the ring is not essential in most strain background (Bi et al, 1998; Schmidt et al, 2002) . Ko et al (2007) found that myo1D/D strains that express a non-degradable version of Iqg1 or overexpressing Iqg1 produces high percentages of separated cells, thereby implying that Iqg1 has an important function in mediating the actomyosin-ring-independent mechanism of cytokinesis. However, overexpression of Cyk3, a neck-localizing protein with yet unknown function, can suppress the lethality of iqg1D without restoring the actomyosin ring (Ko et al, 2007) , suggesting that cytokinesis can occur without both the ring and Iqg1, thereby consistent with our observations in C. albicans. Thus, the mechanisms for the actomyosin-ring-independent cytokinesis remain to be elucidated.
Iqg1 physically and genetically interacts with formins
Assembly of the actomyosin ring requires both Iqg1 and formins in S. cerevisisae. Tolliday et al (2002) suggested that they work synergistically in parallel pathways with formins responsible for creating and Iqg1 for organizing actin filaments. However, it remains possible that Iqg1 and formins may directly interact with and thus regulate each other. Our studies here support this hypothesis. By means of coIP we detected the association of Iqg1 with both Bni1 and Bnr1. And more importantly, we found that Iqg1-15A abolished and Iqg1-15E enhanced this association, suggesting that CDK may regulate the Iqg1-formin interaction through direct phosphorylation of Iqg1. However, the molecular consequence of this interaction remains unclear. In mammalian cells, IQGAP1 is necessary for the subcellular localization of Dia1 . We found that Bni1 localization was hard to detect in iqg1D/D cells, suggesting that Iqg1 may have a function in Bni1 localization. However, we did not observe any significant changes in cellular localizations of either formin in iqg1-15A and iqg1-15E mutants, although the overexpression of formins may have concealed the subtle effects of the CDK-site mutations. As formins are present as components of protein complexes such as polarisomes (Sheu et al, 2000) and both formins and Iqg1 interact with Rho GTPases (Kohno et al, 1996; Tolliday et al, 2002) , it is reasonable to hypothesize that the proper interactions of formin with other proteins might partly depend on Iqg1 at the sites of polarized growth, thereby affecting the quality of morphogenesis and cytokinesis.
Materials and methods
Media and growth conditions
Candida albicans strains were routinely grown in either YPD (1% yeast extract, 2% Bacto peptone, and 2% glucose) or GMM (2% glucose, 1 Â yeast nitrogen base). To grow strains defective in uracil, arginine, or histidine synthesis, the required nutrient was added to the GMM. G1 cells were prepared by centrifugal elutriation as described (Sinha et al, 2007) .
Gene deletion
Gene deletion was done by sequentially deleting the two copies of a gene from BWP17 (Wilson et al, 1999) . A deletion cassette was constructed by flanking a marker gene, CaHIS1 or CaARG4, with AB and CD DNA fragments (B500 bp each) corresponding to the 5 0 and 3 0 -untranslated regions of the target gene, respectively. Transformants were selected using appropriate GMM media. Deletion was verified by Southern blotting or PCR (data not shown).
GFP tagging of proteins
To construct a GFP-Iqg1 fusion protein driven by its native promoter, a 1503-bp fragment of the IQG1 promoter (nt -1503 to -1, the first nt of the start codon is 1) was amplified by PCR with KpnI and XhoI sites added to the 5 0 -and 3 0 -ends, respectively, cleaved with KpnI and XhoI, and cloned at the Kpn I/Xho I sites of the plasmid pCIpGFPutr in front of GFP (Zheng et al, 2003) , yielding pCIpP Iqg1 GFPutr. The N-terminal region of nt 1-1260 of the IQG1 ORF was PCR-amplified with Nar I and Pst I sites added to the 5 0 and 3 0 -ends respectively, cut with NarI and PstI, cloned at the ClaI/PstI sites of pCIpP Iqg1 GFPutr downstream of GFP. The resulting plasmid was cut with BamH1 at nt 648 of the IQG1 ORF and transformed into the IQG1/iqg1D strain. To mutate the N-terminal 15 CDK sites, the IQG1 region of nt 1-1665 was PCR-amplified with NarI and PstI sites added to the 5 0 -and 3 0 -ends, respectively, cut with NarI and PstI and cloned at the ClaI/PstI sites of pCIpP Iqg1 GFPutr downstream of GFP. The resulting plasmid was used to generate the GFP-iqg1-15A and GFP-iqg1-15E mutants using the Quik-Change Multi-Site-Directed Mutagenesis Kit (Stratagene). A unique SalI site was generated at nt 1157 for linearization and transformation into IQG1/iqg1D cells.
Similar strategies were used to express GFP-Myo1. The MYO1 promoter (nt -1352 to -1) was PCR-amplified with KpnI and XhoI sites added to 5 0 -and 3 0 -ends respectively, cut with KpnI and XhoI, and cloned at the KpnI/XhoI sites in pCIpGFPutr, yielding pCIpP Myo1 GFPutr. The MYO1 region of nt 1-1057 was PCR-amplified with NarI and PstI sites added to the 5 0 -and 3 0 -respectively, cut with NarI and PstI, cloned at the ClaI/PstI sites of pCIpP Myo1 GFPutr before cleavage with ClaI at nt 678 of MYO1 for genomic integration.
To tag Iqg1 with an N-terminal 6Myc epitope, the coding sequence for 6Myc (LDEESILKQE) was synthesized with XhoI and ClaI sites added to 5 0 -and 3 0 -ends, respectively, cut with XhoI and ClaI, and cloned at the XhoI/ClaI sites of pCIpP Iqg1 GFPutr, yielding pCIpP Iqg1 Mycutr. The plasmid was cut with BamH1 at nt 648 of IQG1 for genomic integration. Similar strategies were used to generate 6Myc-Iqg1-15A and 6Myc-Iqg1-15E.
Coimmunoprecipitation
Cells were grown in 50 ml GMM overnight and then diluted to 200 ml for 2 h of growth. Cells were harvested and lysed in 1.5 volumes of lysis buffer (50 mM HEPES, pH 7.5, 1 mM EDTA, 5% glycerol, 0.05% Tween 20, 105 mM KCl) with 1 Â protease inhibitor mix (Roche). Cells were lysed using Tomy Microsmash by five rounds of 45-s spin at 5000 r.p.m. with 1-min cooling on ice between rounds. The lysate was clarified by spinning at 10 000 g twice. Protein concentrations were determined using the Bradford assay. Antibody-conjugated beads (15-50 ml) were washed twice with 500 ml of the lysis buffer, added to 0.4-2 ml of the clarified lysate, and incubated at 4 1C for 2 h. After washing twice with the lysis buffer, the beads were boiled in gel loading buffer.
Immunopurification of Myc-Iqg1
To purify Myc-Iqg1 for MS analysis and the in vitro kinase assay, cell lysates were prepared as described above in RIPA buffer ((50 mM Tris-HCl, pH 7.2, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 1 Â EDTA-free protease inhibitor mix, and phosphatase inhibitor cocktail (2 mM NaF, 4 mM sodium orthovanadate, 0.2 mM Na 4 P 2 O 7 , 2.3 mM sodium molybdate, and 0.2 mM b-glycerol phosphate)) and incubated with Myc-antibody-coupled beads (Sc40, Santa Cruz Biotechnology) at 41C for 1 h. To remove non-specific proteins, the buffer contained 500 mM NaCl. After incubation, the beads were washed four times with wash buffer (50 mM Tris-HCl, pH 7.2, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, and 150 mM NaCl).
Protein dephosphorylation
Dephosphorylation of Myc-Iqg1 was performed immediately after IP on the Myc-antibody-conjugated beads in a 100 ml reaction with B1000 U of l-PPase (NEB) at 301C for 30 min.
MS mapping of phosphorylation sites
To map phosphorylation sites, Myc-Iqg1 was immunopurified as described above from 14 l of log-phase cells and then processed as described by Sinha et al (2007) . Actin, nuclear, and cell wall staining and fluorescence microscopy Actin, nuclear, and cell wall staining were performed as described (Zheng et al, 2003) . A Leica DMR fluorescence microscope with Â 100 objective and a Hamamatsu digital camera interfaced with METAMORPH software (Universal Imaging) were used for imaging.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
